- Home
- AKRO vs AG Comparison
AKRO vs AG Comparison
Compare AKRO & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- AG
- Stock Information
- Founded
- AKRO 2017
- AG 1979
- Country
- AKRO United States
- AG Canada
- Employees
- AKRO N/A
- AG N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- AG Precious Metals
- Sector
- AKRO Health Care
- AG Basic Materials
- Exchange
- AKRO Nasdaq
- AG Nasdaq
- Market Cap
- AKRO 3.9B
- AG 3.1B
- IPO Year
- AKRO 2019
- AG N/A
- Fundamental
- Price
- AKRO $49.65
- AG $6.18
- Analyst Decision
- AKRO Strong Buy
- AG Buy
- Analyst Count
- AKRO 8
- AG 2
- Target Price
- AKRO $82.50
- AG $8.75
- AVG Volume (30 Days)
- AKRO 1.9M
- AG 21.9M
- Earning Date
- AKRO 05-12-2025
- AG 05-07-2025
- Dividend Yield
- AKRO N/A
- AG 0.32%
- EPS Growth
- AKRO N/A
- AG N/A
- EPS
- AKRO N/A
- AG N/A
- Revenue
- AKRO N/A
- AG $698,532,000.00
- Revenue This Year
- AKRO N/A
- AG $68.65
- Revenue Next Year
- AKRO N/A
- AG $9.36
- P/E Ratio
- AKRO N/A
- AG N/A
- Revenue Growth
- AKRO N/A
- AG 33.60
- 52 Week Low
- AKRO $17.86
- AG $4.43
- 52 Week High
- AKRO $58.40
- AG $8.06
- Technical
- Relative Strength Index (RSI)
- AKRO 63.34
- AG 53.66
- Support Level
- AKRO $44.94
- AG $5.72
- Resistance Level
- AKRO $49.29
- AG $6.55
- Average True Range (ATR)
- AKRO 3.33
- AG 0.26
- MACD
- AKRO 0.67
- AG 0.06
- Stochastic Oscillator
- AKRO 86.02
- AG 64.62
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.